Peptone is a pioneering brand in the field of Translational Biophysics, specializing in drugging Intrinsically Disordered Proteins (IDPs). With a focus on bringing order to disorder, Peptone is dedicated to discovering novel therapeutics that target IDPs, which are proteins that lack a rigid 3D structure but have critical roles in biological processes within the human body. The team at Peptone leverages their expertise in both physics and biology to develop innovative solutions.

Their core capabilities, including the Oppenheimer Platform, proprietary experiments, next-generation supercomputing, and protein disorder laboratory expertise, enable them to uncover groundbreaking approaches to therapeutic development for challenging IDP targets. Peptone's scientific advancements are backed by over 30 years of combined peer-reviewed research into Intrinsically Disordered Proteins and their unique biological properties. By pushing the boundaries of biophysics, Peptone is revolutionizing the development of therapeutics and making a significant impact on human health.

To learn more about Peptone and their pioneering work in drugging Intrinsically Disordered Proteins, visit their website and contact them for further information